Verition Fund Management
BSX icon

Verition Fund Management’s Boston Scientific BSX Stock Holding History

Verition Fund Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$295K Hold
4,700
– – ﹤0.01% 1784
2025
Q4 		$448K Sell
4,700
-57,100
-92% -$5.6M ﹤0.01% 2743
2025
Q3 		$6.03M Buy
61,800
+6,100
+11% +$632K 0.02% 943
2025
Q2 		$5.98M Buy
55,700
+14,800
+36% +$1.5M 0.03% 945
2025
Q1 		$4.13M Sell
40,900
-92,200
-69% -$9.28M 0.02% 994
2024
Q4 		$11.9M Buy
133,100
+500
+0.4% +$44K 0.05% 448
2024
Q3 		$11.1M Buy
132,600
+8,900
+7% +$702K 0.06% 353
2024
Q2 		$9.53M Buy
123,700
+33,900
+38% +$2.48M 0.05% 370
2024
Q1 		$6.15M Buy
89,800
+77,600
+636% +$4.99M 0.04% 544
2023
Q4 		$705K Buy
+12,200
New +$651K 0.01% 1338
2023
Q1 		– Sell
-15,100
Closed -$699K – 2173
2022
Q4 		$699K Hold
15,100
– – 0.01% 1084
2022
Q3 		$585K Buy
+15,100
New +$606K 0.01% 1784
2022
Q2 		– Sell
-53,000
Closed -$2.35M – 2399
2022
Q1 		$2.35M Buy
53,000
+16,500
+45% +$715K 0.03% 857
2021
Q4 		$1.55M Buy
+36,500
New +$1.53M 0.01% 1028

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Verition Fund Management's BSX Position: Q1 2026 in Review

Verition Fund Management increased its Boston Scientific (BSX) stake by 99% in Q1 2026, buying an estimated $3.79M and bringing the position to 95,375 shares worth $5.98M. The position accounts for 0.04% of the portfolio, ranked #506.

Verition Fund Management first reported a position in BSX in Q3 2013 and has held it in 35 quarters since. The position peaked at $33.8M in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Verition Fund Management held 95,375 shares of Boston Scientific worth $5.98M as of Q1 2026.
  • Verition Fund Management bought 47,438 Boston Scientific shares in Q1 2026, an estimated $3.79M.
  • Boston Scientific made up 0.04% of Verition Fund Management's portfolio in Q1 2026, its #506 holding.
  • Verition Fund Management first reported a position in Boston Scientific in Q3 2013 and has held it in 35 quarters since.
  • Verition Fund Management's Boston Scientific position peaked at $33.8M in Q1 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.